Robyn Karnauskas

Stock Analyst at Truist Securities

(0.72)
# 2365
Out of 5,356 analysts
216
Total ratings
36.36%
Success rate
-5.81%
Average return
44 Stocks
Name Action PT Current % Upside Ratings Updated
ABCL AbCellera Biologics
Maintains: Buy
28 10
2.37 321.94% 2 May 16, 2025
AMGN Amgen
Maintains: Hold
333 298
287.18 3.77% 12 Jan 8, 2025
BMY Bristol-Myers Squibb
Maintains: Strong Buy
62 65
47.8 35.98% 2 Jan 8, 2025
MRK Merck & Co
Downgrades: Hold
130 110
77.59 41.77% 11 Jan 8, 2025
GILD Gilead Sciences
Maintains: Hold
82 83
110.46 -24.86% 15 Aug 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Strong Buy
195 210
187.31 12.11% 8 Jul 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 3 Jun 11, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
340 340
130.4 160.74% 17 May 16, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
26 26
2.35 1006.38% 2 May 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
8 7
0.81 764.2% 13 May 13, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
1135 1135
482.56 135.2% 16 Apr 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10
1.39 619.42% 2 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 9
2.83 218.02% 4 Mar 26, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
74
18.89 291.74% 2 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
23
11.2 105.36% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
48
16.02 199.63% 5 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
50
9.65 418.13% 8 Mar 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
850
764.43 11.19% 4 Mar 22, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
456 508
443.61 14.52% 12 Jan 31, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
42 36
23.1 55.84% 5 Dec 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
29
n/a n/a 1 Oct 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
25
51.76 -51.7% 1 Oct 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 6 Oct 5, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
140
55.28 153.26% 5 Sep 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
150
0.04 374900% 2 Sep 6, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Hold
7
1.35 418.52% 3 Aug 16, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
65 55
16.77 227.97% 1 May 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 4 Dec 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
500 320
30.03 965.6% 2 Aug 23, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
10 15
3.95 279.75% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
12 4
n/a n/a 2 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
65 10
n/a n/a 5 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
32
n/a n/a 4 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
580 120
n/a n/a 1 Mar 2, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
25
n/a n/a 1 Nov 11, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
85
0.37 22872.97% 1 Oct 8, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
180 165
n/a n/a 5 May 23, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
100 77
n/a n/a 6 Dec 17, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
60 44
n/a n/a 3 Aug 20, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
44 63
n/a n/a 3 Mar 1, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
n/a
n/a n/a 3 Feb 16, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Jan 18, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
62 87
n/a n/a 1 Mar 2, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Neutral
6 8
n/a n/a 1 Mar 3, 2016